A well-defined contamination control program is essential to maintain quality through aseptic manufacture of parenteral drug products.
Aaron Mertens
Advertisement
Aaron Mertens is a Microbiologist and Technical Services Manager at STERIS Life Sciences.
Articles by Aaron Mertens
Advertisement
Latest Updated Articles
How a Contamination Control Program Impacts Product SterilityPublished: May 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
PharmTech Weekly News Roundup – Week of November 3, 2025
5
